Position in VRTX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$110,832,384
+$81,617,505 QoQ
Shares Held
223,124
+241.0% QoQ
Ownership
0.088%
of shares outstanding
% of Portfolio
0.55%
of 13F equity value
Holder Rank
#100
of 1,735 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ING GROEP NV holds $202,433,197 across 10 Biotechnology names. VRTX ranks #1 (54.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
223,124 | $110,832,384 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
32,086 | $20,006,904 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
564,600 | $19,981,194 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
103,000 | $19,289,840 | |
| 5 | EXEL |
Exelixis, Inc.
|
311,400 | $16,943,274 | |
| 6 | NKTR |
Nektar Therapeutics
|
100,000 | $6,981,000 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
12,244 | $2,950,436 | |
| 8 | INCY |
Incyte Corp
|
20,633 | $2,338,956 |
All Filings in VRTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $110,832,384 | 223,124 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $29,214,879 | 65,425 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $36,780,643 | 81,129 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $4,695,371 | 11,989 | Shares | Defined | 2025-11-06 | |
| 2024-12-31 | $1,926,516 | 4,784 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $24,899,453 | 53,538 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $30,994,110 | 66,125 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $32,204,744 | 77,043 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $30,556,625 | 75,098 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $29,612,842 | 85,158 | Shares | Defined | 2023-10-27 | |
| 2023-06-30 | $27,594,318 | 78,413 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $13,956,970 | 44,298 | Shares | Defined | 2023-05-09 | |
| 2022-09-30 | $17,379,638 | 60,025 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $16,053,294 | 56,969 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $2,917,905 | 11,181 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $9,659,545 | 43,987 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $4,778,900 | 26,346 | Shares | Defined | 2021-11-02 | |
| 2021-06-30 | $5,207,296 | 25,826 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $3,698,686 | 17,212 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $4,076,392 | 17,248 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $1,568,771 | 5,765 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $636,649 | 2,193 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $3,021,965 | 12,700 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||